Amgen and AstraZeneca have announced that AMAGINE-2(TM), a pivotal, multi-arm Phase 3 trial evaluating two doses of brodalumab in more than 1,800 patients with moderate-to-severe plaque psoriasis...
Scientists at IMBA - Institute of Molecular Biotechnology of the Austrian Academy of Sciences in Vienna have made a major advancement towards a future therapy for butterfly children.
There are plenty of body parts that don't grow back when you lose them. Nails are an exception, and a new study published in The Proceedings of the National Academy of Sciences (PNAS) reveals some of...
Fast facts: The study shows that obesity leads to subclinical heart muscle injury and increases the risk for heart failure even among people without overt heart disease and independently of...
Inovio Pharmaceuticals, Inc. has announced its newest DNA-based cancer immunotherapy targeting melanoma induced a robust and broad immune response in animals and directed cancer-killing T cells...
While investigating a rare genetic disorder, researchers at the University of California, San Diego School of Medicine have discovered that a ubiquitous signaling molecule is crucial to cellular...
A team of researchers from Johns Hopkins Medicine has discovered a receptor on blood vessels that causes the vessel to relax in response to light, making it potentially useful in treating vascular...
For skin cancer, early detection is key in beating the disease. Skin cancer apps for smartphones claim to aid early cancer diagnosis. But how effective are they? We investigate.
A longitudinal study established a link between different ultraviolet (UV) exposure measures in children, such as the number of waterside vacations or sunburns, and biomarkers of melanoma risk...